HSA — authorised 30 December 1992
- Marketing authorisation holder: KING PHARMS
- Status: likely_approved
HSA authorised Alocril on 30 December 1992
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 30 December 1992.
KING PHARMS holds the Singaporean marketing authorisation.